These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6705452)

  • 1. Effects of tricyclic antidepressants on platelet monoamine oxidase activity.
    Reyes E; Lisansky J
    Clin Pharmacol Ther; 1984 Apr; 35(4):531-4. PubMed ID: 6705452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo inhibition of platelet MAO activity by tricyclic antidepressants.
    Sullivan JL; Dackis C; Stanfield C
    Am J Psychiatry; 1977 Feb; 134(2):188-90. PubMed ID: 835743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet MAO and amitriptyline treatment.
    Giller E; Jatlow P; Bialos D; Harkness L; Docherty JP
    Psychiatry Res; 1980 Jul; 2(3):259-65. PubMed ID: 6932067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical correlates of tricyclic antidepressant-mediated inhibition of platelet monoamine oxidase.
    Sullivan JL; Zung WW; Stanfield CN; Cavenar JO
    Biol Psychiatry; 1978 Jun; 13(3):399-407. PubMed ID: 667237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between response to phenelzine and MAO inhibition in a clinical trial of phenelzine, amitriptyline and placebo.
    Raft D; Davidson J; Wasik J; Mattox A
    Neuropsychobiology; 1981; 7(3):122-6. PubMed ID: 7231652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MAO inhibition and control of anxiety following amitriptyline therapy. A pilot study.
    Davidson J; Linnoila M; Raft D; Turnbull CD
    Acta Psychiatr Scand; 1981 Feb; 63(2):147-52. PubMed ID: 7234472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between high platelet MAO activity and response to MAO inhibitor in depressed bipolars: case reports.
    Rihmer Z; Arató M; Bagdy G
    Pharmacopsychiatria; 1983 Jul; 16(4):119-20. PubMed ID: 6634937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [MAO inhibitors and depressive disorders today].
    Bonamy D; Olié JP; Lôo H
    Encephale; 1983; 9(2):123-36. PubMed ID: 6641614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential response patterns to MAO inhibitors and tricyclics.
    Nies A
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):70-7. PubMed ID: 6376487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversible monoamine oxidase-A inhibitors in resistant major depression.
    Nolen WA; Hoencamp E; Bouvy PF; Haffmans PM
    Clin Neuropharmacol; 1993; 16 Suppl 2():S69-76. PubMed ID: 8313400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of amitriptyline on the activity of enzymes participating in biogenic amine metabolism in patients with affective disorders].
    Matsumoto H; Pietruszewska I; Marcjan K
    Psychiatr Pol; 1983; 17(5-6):417-20. PubMed ID: 6669662
    [No Abstract]   [Full Text] [Related]  

  • 12. [Significance of various enzymes of mediator metabolism for evaluation of depression and therapeutic prognosis].
    Vertogradova OP; Misionzhinik EIu; Poliakov SE; Uzbekov MG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1992; 92(1):99-103. PubMed ID: 1319664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers.
    Fisar Z; Hroudová J; Raboch J
    Neuro Endocrinol Lett; 2010; 31(5):645-56. PubMed ID: 21200377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Adverse drug reactions in combined treatment with tricyclic antidepressants and monoamine oxidase inhibitors].
    von Oefele K; Grohmann R; Hippius H; Rüther E
    Nervenarzt; 1988 Feb; 59(2):118-23. PubMed ID: 3362260
    [No Abstract]   [Full Text] [Related]  

  • 15. Absence of platelet monamine oxidase inhibition during amitriptyline or zimelidine treatment.
    Reveley MA; Glover V; Slander M; Coppen A
    Br J Clin Pharmacol; 1979 Oct; 8(4):375-8. PubMed ID: 508514
    [No Abstract]   [Full Text] [Related]  

  • 16. Monoamine oxidase inhibitors as treatment for depressed patients with primary degenerative dementia (Alzheimer's disease).
    Jenike MA
    Am J Psychiatry; 1985 Jun; 142(6):763-4. PubMed ID: 4003602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New contributions from basic science to understanding the effects of monoamine oxidase inhibiting antidepressants.
    Murphy DL; Garrick NA; Aulakh CS; Cohen RM
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):37-43. PubMed ID: 6735994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depression and monoamine oxidase.
    Coper H; Fähndrich E; Gebert A; Helmchen H; Honecker H; Müller-Oerlinghausen B; Pietzcker A
    Prog Neuropsychopharmacol; 1979; 3(5-6):441-63. PubMed ID: 401000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of electroconvulsive therapy and combined phenelzine-amitriptyline in refractory depression.
    Davidson J; McLeod M; Law-Yone B; Linnoila M
    Arch Gen Psychiatry; 1978 May; 35(5):639-42. PubMed ID: 727903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Blood MAO/DBH index and the results of the treatment of endogenous depression].
    Puzyński S; Hauptmann M; Rode A; Kalinowski A; Bidzińska E; Beresewicz M; Bidziński A
    Psychiatr Pol; 1990; 24(3):202-8. PubMed ID: 2084728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.